✦ LIBER ✦

Initial experience with aflibercept in the management of patients with wet age-related macular degeneration refractory to ranibizumab and/or bevacizumab

✍ Scribed by Cervera, R.E.; Castro, V.; Montero, J.; Torralba, C.; Gracia, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rapid response of retinal pigment epithe

✍ Patel, K H; Chow, C C; Rathod, R; Mieler, W F; Lim, J I; Ulanski, L J; Leiderman 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 897 KB

Treatment Patterns of Ranibizumab and Af

✍ Ferreira, A.; Sagkriotis, A.; Milnes, F.; Olson, M.; Hill, J.; Lu, J.; Makin, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

A randomised double-masked trial compari

✍ Krebs, I.; Schmetterer, L.; Boltz, A.; Told, R.; Vecsei-Marlovits, V.; Egger, S. 📂 Article 📅 2013 🏛 BMJ Publishing Group 🌐 English ⚖ 251 KB

A single-arm, investigator-initiated stu

✍ Singh, R. P.; Srivastava, S.; Ehlers, J. P.; Bedi, R.; Schachat, A. P.; Kaiser, 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 992 KB

Adherence by Spanish Retinologists to th

✍ Colomé, A.; Balaña, M.; Ruiz Moreno, J.M.; Roura, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Proteomic analysis of the aqueous humor

✍ Yao, Jiaqi; Liu, Xiaoyi; Yang, Qin; Zhuang, Min; Wang, Feng; Chen, Xi; Hang, Hui 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 891 KB